Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma

Neurofibromatosis type 2 (NF2) is a tumor suppressor gene syndrome characterized by multiple schwannomas, especially vestibular schwannomas (VS), and meningiomas. Anticancer drug trials are now being explored, but there are no standardized endpoints in NF2. We review the challenges of NF2 clinical t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Plotkin, Scott R., Halpin, Chris, Blakeley, Jaishri O., Slattery, William H., Welling, D. Bradley, Chang, Susan M., Loeffler, Jay S., Harris, Gordon J., Sorensen, A. Gregory, McKenna, Michael J., Barker, Fred G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4036446/
https://ncbi.nlm.nih.gov/pubmed/19430883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9867-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk